Cargando…
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines
One of the main goals of vaccine research is the development of adjuvants that can enhance immune responses and are both safe and biocompatible. We explored the application of the natural polymer hyaluronan (HA) as a promising immunological adjuvant for protein-based vaccines. Chemical conjugation o...
Autores principales: | Dalla Pietà, Anna, Carpanese, Debora, Grigoletto, Antonella, Tosi, Anna, Dalla Santa, Silvia, Pedersen, Gabriel Kristian, Christensen, Dennis, Meléndez-Alafort, Laura, Barbieri, Vito, De Benedictis, Paola, Pasut, Gianfranco, Montagner, Isabella Monia, Rosato, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093216/ https://www.ncbi.nlm.nih.gov/pubmed/33762685 http://dx.doi.org/10.1038/s41423-021-00667-y |
Ejemplares similares
-
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer
por: Montagner, Isabella Monia, et al.
Publicado: (2015) -
Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule
por: Carpanese, D., et al.
Publicado: (2023) -
Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
por: Montagner, Isabella Monia, et al.
Publicado: (2020) -
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”
por: Zuccolotto, Gaia, et al.
Publicado: (2021) -
Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs
por: Montagner, Isabella Monia, et al.
Publicado: (2014)